Vault-13

Sands Capital Alternatives, LLC

ARLINGTON, VA · CIK 1846444 · 13F filing filed 2023-08-15

SEC-registered investment adviser since 2011 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Arlington, VA (main office)United States United Statesabout 60
Fitzrovia LondonUnited Kingdom United Kingdom2
San Francisco, CAUnited States United States2
New York City, NYUnited States United States1
San Juan, PRUnited States United States1
SingaporeSingapore Singapore

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$338.1m reported value -16.4% vs Q1 2023
21positions
98.4%in top 10
0 new 3 added 5 reduced 2 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NU HLDGS LTD ORD SHS CL A NU NU 9,152,548 $72.2m21.36% 21.36% ReducedShares held: Q3 2022 9.1m, Q4 2022 9.2m, Q1 2023 9.2m, Q2 2023 9.2m -3.8k -3,799 -0.0%
2 UIPATH INC CL A PATH PATH 3,066,569 $50.8m15.03% 15.03% ReducedShares held: Q3 2022 3.8m, Q4 2022 3.8m, Q1 2023 3.8m, Q2 2023 3.1m -750.0k -750,000 -19.6%
3 DOORDASH INC CL A DASH DASH 603,512 $46.1m13.64% 13.64% UnchangedShares held: Q3 2022 601.5k, Q4 2022 603.5k, Q1 2023 603.5k, Q2 2023 603.5k
4 SAMSARA INC COM CL A IOT IOT 1,543,447 $42.8m12.65% 12.65% ReducedShares held: Q3 2022 326.0k, Q4 2022 332.5k, Q1 2023 2.3m, Q2 2023 1.5m -751.3k -751,329 -32.7%
5 SNOWFLAKE INC CL A SNOW SNOW 215,708 $38.0m11.23% 11.23% AddedShares held: Q3 2022 214.6k, Q4 2022 215.5k, Q1 2023 215.5k, Q2 2023 215.7k +173 +173 0.1%
6 10X GENOMICS INC CL A COM TXG TXG 481,770 $26.9m7.96% 7.96% UnchangedShares held: Q3 2022 481.8k, Q4 2022 481.8k, Q1 2023 481.8k, Q2 2023 481.8k
7 ACRIVON THERAPEUTICS INC COMMON STOCK ACRV ACRV 1,652,605 $21.4m6.34% 6.34% UnchangedShares held: Q3 2022 0, Q4 2022 1.7m, Q1 2023 1.7m, Q2 2023 1.7m
8 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 3,417,075 $16.4m4.86% 4.86% UnchangedShares held: Q3 2022 3.4m, Q4 2022 3.4m, Q1 2023 3.4m, Q2 2023 3.4m
9 OLINK HLDG AB SPONSORED ADS SPONSORED ADS 705,514 $13.2m3.91% 3.91% UnchangedShares held: Q3 2022 705.5k, Q4 2022 705.5k, Q1 2023 705.5k, Q2 2023 705.5k
10 TARSUS PHARMACEUTICALS INC COM TARS TARS 260,000 $4.7m1.39% 1.39% UnchangedShares held: Q3 2022 260.0k, Q4 2022 260.0k, Q1 2023 260.0k, Q2 2023 260.0k
11 SPRUCE BIOSCIENCES INC COM COM 787,007 $1.7m0.50% 0.50% UnchangedShares held: Q3 2022 787.0k, Q4 2022 787.0k, Q1 2023 787.0k, Q2 2023 787.0k
12 908 DEVICES INC COM MASS MASS 237,258 $1.6m0.48% 0.48% ReducedShares held: Q3 2022 326.4k, Q4 2022 326.4k, Q1 2023 326.4k, Q2 2023 237.3k -89.2k -89,169 -27.3%
13 CANDEL THERAPEUTICS INC COM CADL CADL 811,737 $1.0m0.30% 0.30% UnchangedShares held: Q3 2022 811.7k, Q4 2022 811.7k, Q1 2023 811.7k, Q2 2023 811.7k
14 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 724,873 $478.4k0.14% 0.14% UnchangedShares held: Q3 2022 724.9k, Q4 2022 724.9k, Q1 2023 724.9k, Q2 2023 724.9k
15 COUPANG INC CL A CPNG CPNG 8,438 $146.8k0.04% 0.04% AddedShares held: Q3 2022 0, Q4 2022 7.0k, Q1 2023 7.0k, Q2 2023 8.4k +1.5k +1,467 21.0%
16 TOAST INC CL A TOST TOST 6,287 $141.9k0.04% 0.04% AddedShares held: Q3 2022 0, Q4 2022 4.5k, Q1 2023 4.5k, Q2 2023 6.3k +1.8k +1,793 39.9%
17 DATADOG INC CL A COM DDOG DDOG 1,366 $134.4k0.04% 0.04% UnchangedShares held: Q3 2022 0, Q4 2022 1.4k, Q1 2023 1.4k, Q2 2023 1.4k
18 CROWDSTRIKE HLDGS INC CL A CRWD CRWD 744 $109.3k0.03% 0.03% ReducedShares held: Q3 2022 0, Q4 2022 864, Q1 2023 864, Q2 2023 744 -120 -120 -13.9%
19 ABSCI CORPORATION COM ABSI ABSI 57,804 $87.9k0.03% 0.03% UnchangedShares held: Q3 2022 57.8k, Q4 2022 57.8k, Q1 2023 57.8k, Q2 2023 57.8k
20 CONFLUENT INC CLASS A COM CFLT CFLT 1,354 $47.8k0.01% 0.01% UnchangedShares held: Q3 2022 0, Q4 2022 1.4k, Q1 2023 1.4k, Q2 2023 1.4k
21 GITLAB INC CLASS A COM GTLB GTLB 658 $33.6k0.01% 0.01% UnchangedShares held: Q3 2022 0, Q4 2022 658, Q1 2023 658, Q2 2023 658

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
DICE THERAPEUTICS INC 2,748,970 $78.8m2.7m shares
KARUNA THERAPEUTICS INC 58,895 $10.7m58.9k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ACUMEN PHARMACEUTICALS INC ABOS · 13G · filed 2025-08-13 ABOS 5.6%≈ $9.1m 13G 2025-08-13